Results 1 - 10 for cancer news
-
Significant Advances in Lung Cancer Treatment Bring Hope
In 2021, there were more than 10 new drugs approved for lung <b>cancer</b> alone. That is astronomical for cancer. With clinical trials available at different</b> ...
-
Novel Immunotherapy Agent Safe, Shows Promise Against High-Risk ...
Fast Facts. Research @hopkinskimmel shows promise for immunotherapy drug against type of prostate <b>cancer</b>. A new drug, a monoclonal antibody known as</b> ...
-
Novel Drug Combination Shows Promise for Advanced HER2-Negative Breast ...
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast <b>cancer</b>, according to new research directed by</b> ...
-
A Cure for Lung Cancer? | Johns Hopkins Medicine
By Amy Mone on 06/04/2022. Published in Hopkins Medicine - Spring/Summer 2022. Patients with resectable lung <b>cancer</b> have long faced bleak prospects.</b> ...
-
Pancreatic Cancer Vaccine Plus Immunotherapy and Antibody Spark Immune ...
07/17/2023. Credit: Adobe Stock image of pancreatic <b>cancer</b> cells. Fast Facts. Click to Tweet. Combination therapy for #pancreaticcancer by @hopkinskimmel</b> ...
-
Combination Urothelial Cancer Treatment Nearly Doubles Patient Survival ...
Fast Facts. New combo treatment for urothelial <b>cancer</b> nearly doubles patient survival in international trial at @hopkinskimmel and other sites. Combining</b> ...
-
Johns Hopkins Investigators Develop Novel Treatment for T-cell ...
A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its</b> ...
-
A Team Approach | Johns Hopkins Medicine
A Team Approach. Bringing together experts from different specialties to combat esophageal <b>cancer</b>. Esophageal <b>Cancer</b> Team, Johns Hopkins Bayview</b> ...
-
Liquid Biopsy Predicts Immunotherapy Response and Toxicity in Patients ...
By monitoring changes in circulating tumor DNA (ctDNA) among 30 patients treated with immunotherapies for metastatic non-small cell lung <b>cancers</b>, the</b> ...
-
Immunotherapy Combination May Benefit Patients with Transplanted ...
Fast Facts. People who have had a kidney transplant are at high risk for developing skin <b>cancers</b>. New research directed by investigators from the Johns</b> ...
You can also browse:
-
Health
The Johns Hopkins Health section is your A-Z resource on diseases and conditions, tests and procedures, health and wellness information and more.
-
Patient Care
Our innovations in cancer treatment, neurosurgery, transplants, patient safety and more give hope to patients around the world.
-
Research
Our findings in areas ranging from the genetic links of disease to the uses of medical devices point the way to care and cure.
-
School of Medicine
We revolutionized the study of medicine at our founding. We're reimagining the medical curriculum for the 21st century.